A randomized controlled trial of adding intravenous corticosteroids to H1 antihistamines in patients with acute urticaria
The American Journal of Emergency Medicine Mar 02, 2020
Palungwachira P, et al. - Despite the promotion of the use of corticosteroids in addition to H1 antihistamines by guidelines for acute urticaria, scarcity of well-designed clinical trials evaluating this approach was identified. Researchers here randomized 75 adult emergency department patients with acute urticaria and a pruritus score > 5 on a visual analog scale into three groups (25 per group): (i) IV chlorpheniramine (CPM) treatment, (ii) IV CPM and IV dexamethasone (CPM/Dex) and (iii) IV CPM and IV dexamethasone with oral prednisolone as discharge medication for 5 days (CPM/Dex/Pred). As per outcomes, adding IV dexamethasone led to no improvement in the treatment of severe pruritus from uncomplicated acute urticaria. They identified a possible link between oral corticosteroid therapy and persistent urticaria activity. Using corticosteroids as an adjunctive treatment is discouraged because of no identified clinical benefits and the potential for side effects.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries